MoneyWorks4Me

Amanta Healthcare - Quaterly Results

06 Aug 2026 Evaluate
The Revenue for the quarter ended  June 2026 of Rs. 688.03 millions grew by 5.35 % from Rs. 653.07 millions.The Net Profit of the company registered a slight decline of -5.64% to Rs. 33.10  millions from Rs. 35.08 millions.Operating profit for the quarter ended June 2026 decreased to 151.82 millions as compared to 158.55 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 688.03 653.07 5.35 688.03 653.07 5.35 2876.77 2747.08 4.72
Other Income 6.43 9.61 -33.09 6.43 9.61 -33.09 33.71 13.85 143.39
PBIDT 151.82 158.55 -4.24 151.82 158.55 -4.24 632.28 610.53 3.56
Interest 60.05 62.87 -4.49 60.05 62.87 -4.49 207.46 279.48 -25.77
PBDT 91.77 95.68 -4.09 91.77 95.68 -4.09 398.53 331.05 20.38
Depreciation 46.85 46.41 0.95 46.85 46.41 0.95 187.30 183.99 1.80
PBT 44.92 49.27 -8.83 44.92 49.27 -8.83 211.23 147.06 43.64
TAX 11.82 14.19 -16.70 11.82 14.19 -16.70 62.49 42.06 48.57
Deferred Tax 8.34 -2.33 -457.94 8.34 -2.33 -457.94 -23.40 6.14 -481.11
PAT 33.10 35.08 -5.64 33.10 35.08 -5.64 148.74 105.00 41.66
Equity 38.83 28.83 34.69 38.83 28.83 34.69 343.36 282.70 21.46
PBIDTM(%) 22.07 24.28 -9.11 22.07 24.28 -9.11 21.98 22.22 -1.11
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..